NEWS
WSJ | Australia’s Advanced Human Imaging Sets U.S. IPO Terms

Australia-listed app maker Advanced Human Imaging Ltd. on Monday said it plans to sell nearly 1.88 million American depositary shares at between $7 and $9 each in its U.S. initial public offering. At the $8 midpoint of that range, the South Perth company said it expects net proceeds of nearly $13 million, or about $15 […]

Alzheimer’s News Today | Nuravax Acquires Rights for MultiTEP Vaccine Platform Tech

The nonprofit Institute for Molecular Medicine (IMM) has licensed its universal vaccine platform technology — called MultiTEP — to Nuravax, a biotech developing therapies for Alzheimer’s disease and other disorders of the central nervous system. MultiTEP is a vaccine platform that can generate very high levels of antibodies against toxic proteins that clump together in the brains of […]

The Frederick News-Post | New infectious disease research and development center opens in Frederick

With the snip of a ribbon on a windy Monday afternoon, Tonix Pharmaceuticals officially has a research and development center for infectious diseases — and it’s located in Frederick, right down the road from the city’s municipal airport. Standing before the 48,000-square-foot facility, Dr. Seth Lederman — co-founder, CEO and chairman of the 10-year-old biopharmaceutical […]